Ingrid Kane
Technik-/Wissenschafts-/F&E-Leiter bei SIGHT SCIENCES, INC.
Profil
Ingrid Kane is currently the Vice President-Global Medical Affairs at Sight Sciences, Inc. Previously, she worked as the Vice President-Medical Affairs at iScience Interventional Corp.
She holds a doctorate degree from the University of Charles.
Aktive Positionen von Ingrid Kane
Unternehmen | Position | Beginn |
---|---|---|
SIGHT SCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Ingrid Kane
Unternehmen | Position | Ende |
---|---|---|
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ingrid Kane
University of Charles | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SIGHT SCIENCES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |